← Back to headlines
Novo's Wegovy to Be Accessible to 1.2 Million Additional Patients in England
Novo Nordisk's weight-loss drug, Wegovy, is set to become available to an additional 1.2 million patients across England.
1 Apr, 07:10 — 1 Apr, 07:10
Sources
Showing 1 of 1 sources
